title: A Phase 2 Multi-institutional Study to Evaluate Gemcitabine and Fractionated Stereotactic Radiotherapy for Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: A T
authors.initials: AT
authors.lastname: Wild
authors.affiliation: Stanford University, Stanford, CA.
authors.forename: D T
authors.initials: DT
authors.lastname: Chang
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, NY.
authors.forename: K A
authors.initials: KA
authors.lastname: Goodman
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: D A
authors.initials: DA
authors.lastname: Laheru
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: L
authors.initials: L
authors.lastname: Zheng
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: S P
authors.initials: SP
authors.lastname: Raman
authors.affiliation: Stanford University, Stanford, CA.
authors.forename: L A
authors.initials: LA
authors.lastname: Columbo
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: C L
authors.initials: CL
authors.lastname: Wolfgang
authors.affiliation: Stanford University, Stanford, CA.
authors.forename: A C
authors.initials: AC
authors.lastname: Koong
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, MD.
authors.forename: J M
authors.initials: JM
authors.lastname: Herman